3-[[2-ethoxyethyl(ethyl)amino]methyl]-N-[6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;3-[[ethyl(2-methylbutan-2-yl)amino]methyl]-N-[6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;3-ethyl-N-[6-methyl-3-(1,3-thiazol-2-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;3-ethyl-N-(6-methyl-3-thiophen-3-ylimidazo[1,2-a]pyrazin-8-yl)-1,2-thiazol-5-amine;methane;6-methyl-N-[4-[(4-methylpiperidin-1-yl)methyl]phenyl]-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine
C96H114N34OS6 — CID 159632562
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[[2-ethoxyethyl(ethyl)amino]methyl]-N-[6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;3-[[ethyl(2-methylbutan-2-yl)amino]methyl]-N-[6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;3-ethyl-N-[6-methyl-3-(1,3-thiazol-2-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;3-ethyl-N-(6-methyl-3-thiophen-3-ylimidazo[1,2-a]pyrazin-8-yl)-1,2-thiazol-5-amine;methane;6-methyl-N-[4-[(4-methylpiperidin-1-yl)methyl]phenyl]-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine
3-[[2-ethoxyethyl(ethyl)amino]methyl]-N-[6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;3-[[ethyl(2-methylbutan-2-yl)amino]methyl]-N-[6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;3-ethyl-N-[6-methyl-3-(1,3-thiazol-2-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;3-ethyl-N-(6-methyl-3-thiophen-3-ylimidazo[1,2-a]pyrazin-8-yl)-1,2-thiazol-5-amine;methane;6-methyl-N-[4-[(4-methylpiperidin-1-yl)methyl]phenyl]-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine (PubChem CID 159632562) has the molecular formula C96H114N34OS6 and a molecular weight of 1952.61 g/mol. Its IUPAC name is 3-[[2-ethoxyethyl(ethyl)amino]methyl]-N-[6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;3-[[ethyl(2-methylbutan-2-yl)amino]methyl]-N-[6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;3-ethyl-N-[6-methyl-3-(1,3-thiazol-2-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;3-ethyl-N-(6-methyl-3-thiophen-3-ylimidazo[1,2-a]pyrazin-8-yl)-1,2-thiazol-5-amine;methane;6-methyl-N-[4-[(4-methylpiperidin-1-yl)methyl]phenyl]-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine.
Molecular Properties
| Compound Name | 3-[[2-ethoxyethyl(ethyl)amino]methyl]-N-[6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;3-[[ethyl(2-methylbutan-2-yl)amino]methyl]-N-[6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;3-ethyl-N-[6-methyl-3-(1,3-thiazol-2-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;3-ethyl-N-(6-methyl-3-thiophen-3-ylimidazo[1,2-a]pyrazin-8-yl)-1,2-thiazol-5-amine;methane;6-methyl-N-[4-[(4-methylpiperidin-1-yl)methyl]phenyl]-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine |
|---|---|
| PubChem CID | 159632562 |
| Molecular Formula | C96H114N34OS6 |
| Molecular Weight | 1952.61 g/mol |
| Exact Mass | 1950.82 |
| IUPAC Name | 3-[[2-ethoxyethyl(ethyl)amino]methyl]-N-[6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;3-[[ethyl(2-methylbutan-2-yl)amino]methyl]-N-[6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;3-ethyl-N-[6-methyl-3-(1,3-thiazol-2-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine;3-ethyl-N-(6-methyl-3-thiophen-3-ylimidazo[1,2-a]pyrazin-8-yl)-1,2-thiazol-5-amine;methane;6-methyl-N-[4-[(4-methylpiperidin-1-yl)methyl]phenyl]-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine |
| SMILES | C.CCN(Cc1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1)C(C)(C)CC.CCOCCN(CC)Cc1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1.CCc1cc(Nc2nc(C)cn3c(-c4ccsc4)cnc23)sn1.CCc1cc(Nc2nc(C)cn3c(-c4nccs4)cnc23)sn1.Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2ccc(CN3CCC(C)CC3)cc2)n1 |
| InChI | InChI=1S/C23H27N7.C21H28N8S.C20H26N8OS.C16H15N5S2.C15H14N6S2.CH4/c1-16-7-9-29(10-8-16)15-18-3-5-20(6-4-18)28-22-23-24-13-21(19-11-25-26-12-19)30(23)14-17(2)27-22;1-6-21(4,5)28(7-2)13-16-8-18(30-27-16)26-19-20-22-11-17(15-9-23-24-10-15)29(20)12-14(3)25-19;1-4-27(6-7-29-5-2)13-16-8-18(30-26-16)25-19-20-21-11-17(15-9-22-23-10-15)28(20)12-14(3)24-19;1-3-12-6-14(23-20-12)19-15-16-17-7-13(11-4-5-22-9-11)21(16)8-10(2)18-15;1-3-10-6-12(23-20-10)19-13-14-17-7-11(15-16-4-5-22-15)21(14)8-9(2)18-13;/h3-6,11-14,16H,7-10,15H2,1-2H3,(H,25,26)(H,27,28);8-12H,6-7,13H2,1-5H3,(H,23,24)(H,25,26);8-12H,4-7,13H2,1-3H3,(H,22,23)(H,24,25);4-9H,3H2,1-2H3,(H,18,19);4-8H,3H2,1-2H3,(H,18,19);1H4 |
| InChIKey | MPHVCPBMNLDKJQ-UHFFFAOYSA-N |
| XLogP | 21.62 |
| TPSA | 380.54 Ų |
| H-Bond Donors | 8 |
| H-Bond Acceptors | 38 |
| Rotatable Bonds | 31 |
| Heavy Atoms | 137 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1952.61 |
| LogP ≤ 5 | 21.62 |
| H-Bond Donors ≤ 5 | 8 |
| H-Bond Acceptors ≤ 10 | 38 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159632562 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.